⌘K

Login Start Free

Home/Filings/4/0001628280-25-012369

4//SEC Filing

Dier Mardi 4

Accession 0001628280-25-012369

CIK 0001157601other

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:32 PM ET

Size

4.8 KB

Accession

0001628280-25-012369

Insider Transaction Report

Form 4

Period: 2025-03-10

MADRIGAL PHARMACEUTICALS, INC.MDGL

SVP and CFO

Transactions

Sale
Common Stock
2025-03-10$323.04/sh−258$83,344→ 10,440 total

Footnotes (1)

[F1]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024.

Documents

1 file

4
wk-form4_1741811523.xmlPrimary
FORM 4

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother

Related Parties

1

filerCIK 0001574591

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 4:32 PM ET
Size: 4.8 KB

View on SEC.gov